Image source: The Motley Fool.
Arbutus Biopharma (NASDAQ: ABUS)
Q4 2020 Earnings Call
Mar 04, 2021 , 8:45 a.m. ET
Operator
For further details see:
Arbutus Biopharma (ABUS) Q4 2020 Earnings Call TranscriptImage source: The Motley Fool.
Arbutus Biopharma (NASDAQ: ABUS)
Q4 2020 Earnings Call
Mar 04, 2021 , 8:45 a.m. ET
Operator
For further details see:
Arbutus Biopharma (ABUS) Q4 2020 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Arbutus Biopharma Corporation Company Name:
ABUS Stock Symbol:
Market:
Arbutus Biopharma Corporation Website:
On-track to report key clinical data in 2024 from two on-going Phase 2a clinical trials with imdusiran and the Phase 1a/1b clinical trial with AB-101 Plans to initiate a third Phase 2a clinical trial with imdusiran in first half of 2024 Claim Construction for Moderna LNP litigat...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
WARMINSTER, Pa., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (NASDAQ:ABUS), a clinical-stage biopharmaceutical company lever...